SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Aurobindo Pharma

Aurobindo Pharma

BSE: 524804 | NSE: AUROPHARMA | ISIN: INE406A01037 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jan 30, 16:30
1248.10
25.40 (+2.08%)
VOLUME 53,129
AVERAGE VOLUME
5-Day 62,501
10-Day 59,470
30-Day 58,670
VOLUME SHOCKER
5-Day 62,501
10-Day 59,470
30-Day 58,670
Prev. Close
1222.70
Open Price
1228.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 1225.30 1251.85
52 Wk Low/High 453.00 1251.85
LIVE
NSE
Jan 30, 16:30
1247.75
26.20 (+2.14%)
VOLUME 734,125
AVERAGE VOLUME
5-Day 909,405
10-Day 778,111
30-Day 818,869
VOLUME SHOCKER
5-Day 909,405
10-Day 778,111
30-Day 818,869
Prev. Close
1221.55
Open Price
1225.00
Bid PRICE (QTY.)
1247.75 (644)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 1225.00 1252.00
52 Wk Low/High 453.00 1252.00
Action in Aurobindo Pharma

Aurobindo Pharm
Sentimeter

25%25%50%
BUYSELLHOLD

50% of moneycontrol users recommend holding Aurobindo Pharm. What's your call on Aurobindo Pharm today?
Read 19 investor views

MARKET CAP (Rs Cr)
36,419.05
*P/E
22.29
*BOOK VALUE (Rs)
137.51
DIV (%)
300.00%
Market Lot
1
INDUSTRY P/E
26.23
*EPS (TTM)
55.99
*P/C
20.01
*PRICE/BOOK
9.08
DIV YIELD.(%)
0.24%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
29.24 new
DELIVERY AVERAGES
3-Day 36.74%
5-Day 40.53%
8-Day 40.23%
* Based on standalone numbers
Track Aurobindo Pharm on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 04-Feb-2015 (Quarterly Results & 2nd Interim Dividend)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

30 January 2015

buy

Century Jan Fut

Entry Price (Rs)

580.00

Exit Price (Rs)

584.00

Gain (Rs)

4.00

buy

TataChemicals Jan Fut

Entry Price (Rs)

462.00

Exit Price (Rs)

467.00

Gain (Rs)

5.00

sell

BankIndia Jan Fut

Entry Price (Rs)

275.00

Exit Price (Rs)

268.00

Gain (Rs)

7.00

sell

BankBaroda Jan Fut

Entry Price (Rs)

215.00

Exit Price (Rs)

207.00

Gain (Rs)

8.00

buy

Grasim Jan Fut

Entry Price (Rs)

3,915.00

Exit Price (Rs)

3,935.00

Gain (Rs)

20.00

buy

NIFTY Jan Fut

Entry Price (Rs)

8,881.00

Exit Price (Rs)

8,955.00

Gain (Rs)

74.00

F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 437.50 1228.00  
High Price 458.10 1251.85  
Low Price 431.00 1225.30  
Last Price 453.55 1248.10 175.18
Volume 1,104,839 53,129 -95.19
Simple Moving Averages
Days BSE NSE
30 1141.97 1142.06
50 1132.62 1132.63
150 937.98 937.95
200 856.45 856.44

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Aurobindo Pharm

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Sep '14)
(Jun '14)
Net Sales 2,862.19 2,894.61
Other Income 27.29 10.81
PBDIT 664.50 668.96
Net Profit 371.23 414.27

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Jun '14)
(In Rs Cr)
Total Share Capital 29.15
Net Worth 4012.39
Total Debt 2814.86
Net Block 1937.94
Investments 872.62
Net Current Assets 3812.80
Total Assets 6827.25
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 915.95 -0.35 939.05 552.50 189,708.26
Lupin 1584.35 1.86 1589.40 882.80 71,189.88
Cipla 696.05 0.11 711.45 366.70 55,890.06
Dr Reddys Labs 3237.00 -3.64 3662.00 2250.00 55,151.92
Aurobindo Pharm 1248.10 2.08 1251.85 476.75 36,419.05
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Mar' 14Sep' 13
Promoter54.1054.3454.6154.84
FII27.7227.5923.7419.76
DII7.957.739.8511.58
Others10.2310.3411.8013.82
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Plot No. 2, Maitrivihar,,Ameerpet
City
Hyderabad
State
Telangana
Pin Code
500038
Tel. No.
040-23736370
Fax No.
040-23746833 040-23747340
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Telangana
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
K Ragunathan
Non Executive Chairman
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
N Govindarajan
Managing Director
M Sivakumaran
Whole Time Director
M Madan Mohan Reddy
Whole Time Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Nile Recommended on Oct 23rd 2014

Recommended price 186.00  |  Peak from reco 371.40 100.16%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Aurobindo Pharm

Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 36,419.05 crore.The company has reported a consolidated sales of Rs 2,862.19 crore and a Net Profit of Rs 371.23 crore for the quarter ended Sep 2014.

The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director.

It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.

Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Telangana - 500038.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Aurobindo Pharm